Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | CTSK | P43235 | 10/20 | 0.55 |
| ▸ | CTSL | P07711 | 8/20 | 0.55 |
| ▸ | CTSB | P07858 | 6/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | CTSS | P25774 | 8/20 | 0.53 |
| ▸ | CCR4 | P51679 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6275061 | 0.92 | NPSR1 (0.55) | NPSR1LMNACTSKCTSLCTSB | |
| SCHEMBL6239838 | 0.90 | NPSR1 (0.74) | NPSR1LMNACTSKCTSLCTSB | |
| SCHEMBL6238387 | 0.84 | LMNA (0.62) | NPSR1LMNACTSKCTSLCTSB | |
| SCHEMBL6239305 | 0.83 | GBA1 (0.52) | NPSR1CTSKCTSLCTSBMAPT | |
| SCHEMBL6235199 | 0.82 | NPSR1 (0.64) | NPSR1LMNAGAAMAPTKMT2A | |
| SCHEMBL6239273 | 0.82 | GBA1 (0.53) | NPSR1LMNACTSKCTSLCTSB | |
| SCHEMBL5257444 | 0.78 | CTSK (0.62) | NPSR1LMNACTSKCTSLCTSB | |
| SCHEMBL5252198 | 0.78 | CTSK (0.54) | NPSR1LMNACTSKCTSLCTSB | |
| SCHEMBL6234951 | 0.78 | CTSK (0.61) | NPSR1LMNACTSKCTSLCTSB | |
| SCHEMBL6263878 | 0.77 | ALDH1A1 (0.56) | NPSR1LMNACTSKCTSLCTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010059418-A1 | SUBSTITUTED TRIAZINE AND PURINE COMPOUNDS, METHODS OF INHIBITING CRUZAIN AND RHODESAIN AND METHODS OF TREATING CHAGAS DISEASE AND AFRICAN TRYPANOSOMIASIS | THE GOVERNMENT OF THE U.S.A. AS REPRESENTED BY THE SECRETARY OF THE DEPT. OF HEALTH & HUMAN SERVICES (US) | 2010-05-27 | — | — | WO | disclosed |
| WO-2005011703-A1 | 2-CYANO-1,3,5-TRIAZINE-4,6-DIAMINE DERIVATIVES | AKZO NOBEL N.V. (NL) | 2005-02-10 | — | — | WO | disclosed |